Cardiac Amyloidosis

ASNC is the premier source for education and quality in the rapidly expanding area of cardiac amyloidosis. Through its initiatives and partnerships, ASNC is supporting a collaborative approach to awareness, early diagnosis and effective treatments that will save lives and improve quality of life for patients with CA.

ASNC is uniquely qualified to provide education, information and advocacy that ensures appropriate referrals for Tc-99m PYP imaging; supports high-quality testing, interpretation and reporting of Tc-99m PYP imaging by imagers; and encourages fair reimbursement of Tc-99m PYP services and approval of CA treatment agents.

Access the latest educational resources and activities incuding our new app and share with your colleagues!
 

 ONDEMAND WEBINARS | RESOURCES | PUBLICATIONS

 

Latest Webinars

 Now on-demand! - Cardiac Amyloidosis in Japan: Read with the Experts (In Japanese with English slides)

Webinar description:
The objective of the webinar is to review the role of nuclear cardiology imaging in cardiac amyloidosis and to provide comprehensive recommendations based on literature evidence and expert opinion. The focus of this activity is the standardization of image acquisition, interpretation, and reporting based on clinical examples. 

Program Director: 
Jun HASHIMOTO, MD, PhD
Department of Radiology, 
Tokai University School of Medicine
Isehara, JAPAN

Presenter and Chair:
Takashi KUDO, MD, PhD
Department of Radioisotope Medicine,
Atomic Bomb Disease Institute, Nagasaki University
Nagasaki, JAPAN

Presenters:
Kenichi TSUJITA, MD, PhD
Department of Cardiovascular Medicine,
Graduate School of Medical Sciences, Kumamoto University
Kumamoto, JAPAN

Toru KUBO, MD, PhD
Department of Cardiology and Geriatrics,
Kochi Medical School, Kochi University
Kochi, JAPAN

Faculty - Commenting Panel:
Naoya MATSUMOTO, MD, PhD
Department of Cardiology
Nihon University Hospital
Tokyo, JAPAN

Keisuke KISO, MD, PhD
Department of Diagnostic Radiology
Tohoku University Hospital
Sendai, JAPAN

Registration is complimentary.

Acknowledgement of Commercial Support
This activity is supported by an unrestricted educational grant from Pfizer Inc. No CME/CE provided

Session presentations

• Dr. Kubo's presentation 
• Dr. Tsujita's presentation
• Dr.Kudo's presentation

Program Handout

Download the Clinical and Quality Resources App Get up-to-date information on cardiac amyloidosis in eight languages: Chinese, English, French, German, Italian, Japanese, Portuguese and Spanish Topics include: Diagnostic criteria and appropriate imaging utilization in cardiac amyloidosis among others Download Now!

Hover over the QR code with your camera to download